John R Mackey Selected Research

Overweight

1/2016	The Alberta Moving Beyond Breast Cancer (AMBER) Cohort Study: Recruitment, Baseline Assessment, and Description of the First 500 Participants.
9/2014	Effects of exercise during adjuvant chemotherapy on breast cancer outcomes.
11/2002	The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Mackey Research Topics

Disease

109	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2002
74	Neoplasms (Cancer) 01/2022 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 10/2004
9	Adenocarcinoma 07/2017 - 02/2002
8	Fatigue 01/2018 - 06/2007
7	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2006
6	Cardiotoxicity 01/2022 - 07/2011
5	Triple Negative Breast Neoplasms 10/2021 - 03/2011
5	Carcinoma (Carcinomatosis) 01/2014 - 05/2006
4	Heart Failure 03/2019 - 11/2009
4	Anemia 01/2016 - 08/2004
3	Disease Progression 01/2022 - 01/2010
3	Hypertension (High Blood Pressure) 01/2022 - 04/2011
3	Ventricular Remodeling 03/2017 - 08/2009
3	Carcinogenesis 01/2016 - 01/2010
3	Overweight 01/2016 - 11/2002
3	Lymphedema (Milroy Disease) 11/2012 - 10/2007
2	Inflammation (Inflammations) 01/2022 - 03/2019
2	Hypoxia (Hypoxemia) 10/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
2	Lymphoma (Lymphomas) 10/2020 - 10/2003
2	Liver Diseases (Liver Disease) 01/2020 - 01/2020
2	Sarcopenia 01/2016 - 04/2009
2	Stomach Neoplasms (Stomach Cancer) 05/2010 - 01/2005
2	Osteoporosis 02/2010 - 05/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2008 - 01/2005
2	Hodgkin Disease (Hodgkin's Disease) 06/2008 - 07/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2007 - 09/2005
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2004 - 10/2003
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
19	Gemcitabine FDA Link 11/2021 - 01/2002
15	AnthracyclinesIBA 01/2022 - 08/2004
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
12	Equilibrative Nucleoside Transporter 1IBA 12/2019 - 01/2002
11	Hormones (Hormone)IBA 01/2022 - 05/2003
11	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2004
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 05/2007
8	Estrogen ReceptorsIBA 01/2022 - 06/2008
8	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2002
8	taxaneIBA 01/2015 - 08/2004
7	human ERBB2 proteinIBA 01/2022 - 12/2006
7	Pharmaceutical PreparationsIBA 02/2021 - 02/2002
7	Biological ProductsIBA 03/2019 - 01/2005
7	NucleosidesIBA 01/2014 - 01/2002
6	ErbB Receptors (EGF Receptor)IBA 03/2017 - 12/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2014 - 09/2005
6	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2009 - 10/2004
5	Estrogens (Estrogen)FDA Link 01/2022 - 05/2005
5	Taxoids (Taxanes)IBA 05/2017 - 04/2008
4	Messenger RNA (mRNA)IBA 11/2021 - 05/2004
4	RNA (Ribonucleic Acid)IBA 10/2021 - 03/2011
4	Epirubicin (Ellence)FDA LinkGeneric 10/2021 - 04/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2016 - 08/2010
4	Tamoxifen FDA LinkGeneric 02/2016 - 05/2005
4	beta-Aminoethyl Isothiourea (AET)IBA 01/2016 - 12/2007
4	Anastrozole (Arimidex)FDA LinkGeneric 02/2010 - 05/2005
4	Capecitabine (Xeloda)FDA Link 04/2009 - 01/2002
3	AmberIBA 03/2022 - 11/2012
3	Oxygen (Dioxygen)IBA 01/2022 - 06/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2005
3	AntibodiesIBA 01/2020 - 07/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2003
3	TubulinIBA 05/2017 - 06/2007
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2015 - 03/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2011 - 08/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2011 - 06/2007
3	thiamine triphosphorate (TTP)IBA 04/2009 - 10/2004
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 10/2021 - 04/2016
2	UridineIBA 10/2021 - 04/2016
2	glycylpeptide N-tetradecanoyltransferaseIBA 02/2021 - 10/2020
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 01/2020
2	AntioxidantsIBA 01/2018 - 02/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2017 - 07/2011
2	MicroRNAs (MicroRNA)IBA 01/2016 - 09/2015
2	CytokinesIBA 09/2015 - 08/2006
2	Peptides (Polypeptides)IBA 08/2015 - 01/2002
2	RamucirumabIBA 01/2015 - 07/2010
2	Deoxycytidine KinaseIBA 01/2014 - 05/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2014 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 11/2002
2	Bevacizumab (Avastin)FDA Link 10/2012 - 04/2011
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 08/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 07/2010
2	Phosphotransferases (Kinase)IBA 11/2010 - 09/2005
2	Hemoglobins (Hemoglobin)IBA 11/2010 - 09/2008
2	Monoclonal AntibodiesIBA 11/2009 - 01/2002
2	fludarabineIBA 11/2008 - 01/2005
2	DeoxycytidineIBA 07/2007 - 05/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2004 - 10/2003

Therapy/Procedure

56	Therapeutics 01/2022 - 01/2002
52	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
16	Adjuvant Chemotherapy 07/2021 - 09/2005
3	Caloric Restriction 10/2021 - 01/2018
3	Neoadjuvant Therapy 01/2019 - 04/2011
3	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 11/2002
2	Resistance Training 07/2021 - 09/2014
2	Palliative Care (Palliative Therapy) 01/2013 - 11/2008
2	Aftercare (After-Treatment) 11/2012 - 08/2002
2	Radiotherapy 04/2009 - 05/2003